Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

FDA lifts restrictions on Avandia use

US regulator says GSK’s diabetes drug does not increase heart attack risk

- PMLiVE

Two firms join Merck Serono’s Israeli bioincubator

Metabomed to focus on cancer while ChanBio is developing treatments for MS

- PMLiVE

BTG rises on FDA approval of varicose vein therapy

Varithena receives green light in US

National Institute for Health and Care Excellence NICE logo

NICE backs two eye treatments

Novartis’ Lucentis and Alimera’s Iluvien received green light for NHS use

- PMLiVE

Personalised cancer support app wins Janssen’s digital prize

Px HealthcareCare takes first place, ahead of DrEd and Onco Drug Personalized Med

- PMLiVE

Syros appoints Moderna CEO to board

Stéphane Bancel also has experience at bioMérieux and Lilly

Perry Evans joins PiR Resourcing

Takes up client services director post at Cambridgeshire firm

- PMLiVE

Pharma should not ignore India

It’s complicated, but multinational pharma cannot ignore a market with one billion plus people

- PMLiVE

Melinta names chief medical officer

Sue Cammarata has experience at Shire and Novartis

- PMLiVE

ViiV’s Tivicay for HIV on course for EU approval

More positive news for GSK, Pfizer and Shionogi joint venture

- PMLiVE

BMS/AZ’s diabetes drug among CHMP recommendations

Xigduo one of six new drugs backed in EU

Bayer symbol

Bayer offers $2.4bn to buy Xofigo partner Algeta

Norwegian firm says negotiations still at 'an early stage'

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links